logo logo
  • Home
  • Taiwan Healthcare+ Portal
  •  Visitor Login
  • About
    • The Expo
    • 2025 Post-Show Report
    • 2025 Event Highlights
  • Exhibit
    • Exhibitor Apply 2026
    • Exhibit at the Expo
    • Exhibitor Kit 2026
    • Key Dates for Exhibitors
    • Exhibitor Login
    • 2025 Key Visual / Banner / Invitation Card
    • Exhibitor FAQ
  • Visit
    • The Expo
    • Visitor Registration
    • Visitor Login
    • Exhibitor List
    • Visa Information
    • Transportation
    • Hotel Information
  • B2B
    • Healthcare+ B2B
    • Apply as a Corporate Member (Exhibitor)
  • Events
    • 2025 Events Overview
    • 12/3 8th Medtex Summit Asia
    • 12/4-5 B2B 1-on-1 meeting
    • 12/4-6 Networking Reception
    • 12/6 2nd Asia-Pacific Healthcare Quality Forum
  • News
    • Expo News
    • Exhibitor News
    • 2025 Media Coverage
  1. Expo
  2. News Centre
  3. Exhibitor News
  4. 2020
  5. Biopharmaceutical & pharma services
圖片1.jpg
Molecular Biomarker Antibodies Detection Technology for Lung Cancer
Recently, lung cancer can only be screened by medical image technology such as X-ray and CT (LDCT), and confirmed by the biopsy. The screening module developed by VITAE biomedical Co., Ltd. is the only lung cancer test method that can be detected by biomolecular markers.
2020-11-16
圖片一.jpg
ZwickRoell —Over 160 years’ experience in material & components testing machine.
ZwickRoell is the world's leading supplier of materials testing machines.
With a large portfolio of testing machines and accessories cover almost every segment, from medical & pharmaceutical packaging to orthopaedics and surgical instruments. We offer a flexible, modular system of machines, specimen grips, and software to equip your lab efficiently and economically. We provides the right solution for any testing requirement, saving you time and money.
2020-11-16
Exhibit
Exhibitor Apply
Visit
Visitor Registration
Healthcare+ B2B
About the Expo
Expo by Year
Contact us
© 2026 Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy